Aberrantly increased expression of nestin has been detected in various human malignant neoplasms, such as breast cancer [32], gliomas [35], melanomas [40], prostate cancer [36], gastrointestinal cancer [41, 42] and other cancer types [43–45]. This evidence concerns the gene NES and central nervous system cancer.